Allan H Young

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. ncbi Lithium in mood disorders: increasing evidence base, declining use?
    Allan H Young
    Institute of Mental Health, University of British Columbia, University Boulevard, Vancouver, British Columbia, Canada V6T 1Z3
    Br J Psychiatry 191:474-6. 2007
  2. ncbi A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)
    Allan H Young
    Institute of Mental Health, Department of Psychiatry, The University of British Columbia, Vancouver, British Columbia BC V6T 1Z3, Canada
    J Clin Psychiatry 71:150-62. 2010
  3. ncbi A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania
    Lakshmi N Yatham
    Division of Mood Disorders, University of British Columbia, UBC Hospital, Vancouver, British Columbia, Canada
    Int Clin Psychopharmacol 22:212-20. 2007
  4. ncbi Bipolar disorder: diagnostic conundrums and associated comorbidities
    Allan H Young
    Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
    J Clin Psychiatry 70:e26. 2009
  5. ncbi Identifying neurocognitive impairment in depression using computerized testing
    Grant L Iverson
    University of British Columbia, Vancouver, Canada
    Appl Neuropsychol 16:254-61. 2009
  6. ncbi Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study
    Allan H Young
    Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, Canada
    Br J Psychiatry 194:40-8. 2009
  7. ncbi Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients
    Ric M Procyshyn
    British Columbia Mental Health and Addictions Research Institute, A3 113, 938 W 28th Ave, Vancouver, British Columbia, Canada, V5Z 4H4
    J Clin Psychiatry 71:566-73. 2010
  8. ncbi Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets
    Sidney H Kennedy
    University Health Network, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    J Affect Disord 132:S21-8. 2011
  9. ncbi Treatment of bipolar disorder with antipsychotic medication: issues shared with schizophrenia
    Allan H Young
    Department of Psychiatry, University of British Columbia Institute of Mental Health, Vancouver, Canada
    J Clin Psychiatry 68:24-5. 2007
  10. ncbi Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
    Lakshmi N Yatham
    Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada
    Bipolar Disord 11:225-55. 2009

Detail Information

Publications53

  1. ncbi Lithium in mood disorders: increasing evidence base, declining use?
    Allan H Young
    Institute of Mental Health, University of British Columbia, University Boulevard, Vancouver, British Columbia, Canada V6T 1Z3
    Br J Psychiatry 191:474-6. 2007
    ..Recent meta-analyses confirm the benefits of maintenance lithium treatment and show that it reduces suicide and suicidality. Psychiatrists should continue to utilise this efficacious treatment for bipolar disorder...
  2. ncbi A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)
    Allan H Young
    Institute of Mental Health, Department of Psychiatry, The University of British Columbia, Vancouver, British Columbia BC V6T 1Z3, Canada
    J Clin Psychiatry 71:150-62. 2010
    ..The aim of this study was to compare the efficacy and tolerability of quetiapine and lithium monotherapy with that of placebo for a major depressive episode in bipolar disorder...
  3. ncbi A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania
    Lakshmi N Yatham
    Division of Mood Disorders, University of British Columbia, UBC Hospital, Vancouver, British Columbia, Canada
    Int Clin Psychopharmacol 22:212-20. 2007
    ..Overall, the combination of quetiapine with lithium or divalproex was well tolerated...
  4. ncbi Bipolar disorder: diagnostic conundrums and associated comorbidities
    Allan H Young
    Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
    J Clin Psychiatry 70:e26. 2009
    ..To correctly diagnose patients with bipolar disorder, clinicians must be aware of associated comorbidities and methods of differentiating bipolar disorder from other illnesses...
  5. ncbi Identifying neurocognitive impairment in depression using computerized testing
    Grant L Iverson
    University of British Columbia, Vancouver, Canada
    Appl Neuropsychol 16:254-61. 2009
    ..Computerized testing, using the interpretive methodology presented, represents an efficient methodology for identifying cognitive problems in patients who present with untreated depression...
  6. ncbi Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study
    Allan H Young
    Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, Canada
    Br J Psychiatry 194:40-8. 2009
    ..Well-tolerated and effective therapies for bipolar mania are required...
  7. ncbi Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients
    Ric M Procyshyn
    British Columbia Mental Health and Addictions Research Institute, A3 113, 938 W 28th Ave, Vancouver, British Columbia, Canada, V5Z 4H4
    J Clin Psychiatry 71:566-73. 2010
    ....
  8. ncbi Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targets
    Sidney H Kennedy
    University Health Network, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    J Affect Disord 132:S21-8. 2011
    ..This is of particular importance when considering the long term use of antidepressant therapies for relapse prevention...
  9. ncbi Treatment of bipolar disorder with antipsychotic medication: issues shared with schizophrenia
    Allan H Young
    Department of Psychiatry, University of British Columbia Institute of Mental Health, Vancouver, Canada
    J Clin Psychiatry 68:24-5. 2007
    ..These include similar motivations for switching due to limited efficacy and unacceptable adverse effects. Particular attention must be paid to the phase of treatment and coprescribed medications...
  10. ncbi Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
    Lakshmi N Yatham
    Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada
    Bipolar Disord 11:225-55. 2009
    ..Bipolar II disorder is frequently overlooked in treatment guidelines, but has an important clinical impact on patients' lives. This update provides an expanded look at bipolar II disorder...
  11. ncbi Burden of bipolar depression: impact of disorder and medications on quality of life
    Erin E Michalak
    Division of Mood Disorders, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
    CNS Drugs 22:389-406. 2008
    ..Nonetheless, QOL appears to be a meaningful and important indicator of outcome and recovery in this patient population, and one that warrants further scientific interest and energy...
  12. ncbi Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function
    Kelly A Butts
    Department of Psychiatry, University of British Columbia, Vancouver, Canada V6T 1Z3
    Proc Natl Acad Sci U S A 108:18459-64. 2011
    ..Taken together, these data demonstrate that glucocorticoids act locally within the prefrontal cortex to modulate mesocortical dopamine efflux leading to the cognitive impairments observed during acute stress...
  13. ncbi Prenatal alcohol exposure and chronic mild stress differentially alter depressive- and anxiety-like behaviors in male and female offspring
    Kim G C Hellemans
    Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada
    Alcohol Clin Exp Res 34:633-45. 2010
    ..We tested the hypothesis that exposure to stressors in adulthood may unmask an increased vulnerability to depressive- and anxiety-like behaviors in PAE animals...
  14. ncbi Rapid computerized assessment of neurocognitive deficits in bipolar disorder
    Grant L Iverson
    Department of Psychiatry, University of British Columbia, Vancouver, BC, V6T 2A1, Canada
    Appl Neuropsychol 16:207-13. 2009
    ..6% of the bipolar sample and only 6.4% of the control sample scored in this range. A subset of outpatients with bipolar disorder has frank neurocognitive impairments identifiable with this 30-40-minute computerized assessment battery...
  15. ncbi Lithium in maintenance therapy for bipolar disorder
    Allan H Young
    University of Newcastle, Newcastle upon Tyne, UK
    J Psychopharmacol 20:17-22. 2006
    ..It is also associated with an increased liability for new episodes, both manic and depressive, consequent upon stoppage of treatment. These factors limit the clinical effectiveness of lithium...
  16. ncbi Managing the aftermath of mania - Newcastle, 2 September 2005: Consensus Meeting Statement
    Allan H Young
    University of Newcastle, Newcastle upon Tyne, UK
    J Psychopharmacol 20:51-4. 2006
  17. ncbi The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary
    Guy M Goodwin
    J Psychopharmacol 17:3-6. 2003
    ..It is timely since awareness of the specific needs of bipolar patients is growing and there is an increased choice of effective treatments for all phases of the illness...
  18. ncbi Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients
    Stuart Watson
    The Stanley Research Centre, School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, UK
    Psychoneuroendocrinology 32:464-9. 2007
    ..These data demonstrate that patients taking lithium have elevated post-dexamethasone AVP levels compared to both healthy controls and patients not on lithium...
  19. ncbi Soft neurological signs do not increase with age in euthymic bipolar subjects
    Utpal Goswami
    Department of Psychiatry, West Park Hospital, Darlington, Co Durham, DL2 2TS, UK
    J Affect Disord 103:99-103. 2007
    ..This paper explores changes in SNS with ageing to ascertain whether BD is associated with a progressive neurological decline or a relatively fixed, persistent deficit...
  20. ncbi Bipolar patients show mood-congruent biases in sensitivity to facial expressions of emotion when exhibiting depressed symptoms, but not when exhibiting manic symptoms
    John Gray
    St Nicholas' Hospital and University of Newcastle upon Tyne, UK
    Cognit Neuropsychiatry 11:505-20. 2006
    ..There is little evidence of similar biases in persons with bipolar disorder when manic. CONCLUSIONS: These data show a mood-congruent bias in sensitivity to facial expressions in bipolar depressed patients...
  21. ncbi Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder
    Peter Gallagher
    School of Neurology, Neurobiology and Psychiatry, Newcastle University, UK
    Schizophr Res 90:258-65. 2007
    ..These data suggest that afternoon hypercortisolaemia is evident in symptomatic bipolar and schizophrenic patients compared to controls. However, an elevation in DHEA levels may represent a specific endocrine marker in schizophrenia...
  22. ncbi Developing the BALANCE trail--the role of the pilot study and start-up phase
    Jennifer M Rendell
    Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK
    Bipolar Disord 6:26-31. 2004
    ..BALANCE is now actively recruiting in the UK and USA...
  23. ncbi Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia
    Paul Mackin
    School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, Leazes Wing Psychiatry, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK
    Aust N Z J Psychiatry 41:321-6. 2007
    ..The aim of the present study was to investigate BDNF levels in patients with bipolar disorder and schizophrenia before and after treatment with the glucocorticoid receptor antagonist mifepristone...
  24. ncbi The nature of abnormal language processing in euthymic bipolar I disorder: evidence for a relationship between task demand and prefrontal function
    Vivienne A Curtis
    Division of Psychological Medicine, Institute of Psychiatry, London, UK
    Bipolar Disord 9:358-69. 2007
    ..We used functional magnetic resonance imaging (fMRI) to investigate the core components of language processing as well as the impact of task demand in a group of bipolar subjects...
  25. ncbi Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials
    Lesley A Smith
    Medical Research Matters, Eynsham, UK
    Bipolar Disord 9:394-412. 2007
    ..Bipolar disorder (BD) is a leading cause of disability. Systematic reviews of randomized trials for the treatment of the maintenance phase of BD are lacking...
  26. ncbi Impaired working memory monitoring in euthymic bipolar patients
    Jill M Thompson
    School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
    Bipolar Disord 9:478-89. 2007
    ..However, the component operations that contribute to this deficit remain unclear. The aim of the present study was to further profile the nature and specificity of WM impairment in euthymic BD...
  27. ncbi Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia
    Peter Gallagher
    School of Neurology, Neurobiology and Psychiatry, Newcastle University, Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
    J Psychiatr Res 42:1037-41. 2008
    ..This may in part underlie the putative therapeutic effects of such drugs...
  28. ncbi The art and science of switching of antipsychotic medications, part 1
    Peter J Weiden
    Department of Psychiatry, Schizophrenia Research Program, State University of New York Downstate Medical Center, Brooklyn, USA
    J Clin Psychiatry 67:e15. 2006
    ....
  29. ncbi The armamentarium of treatments for bipolar disorder: a review of the literature
    David A Cousins
    Newcastle Magnetic Resonance Centre, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne, UK
    Int J Neuropsychopharmacol 10:411-31. 2007
    ..Our results suggest a growing role for atypical antipsychotics in the treatment of bipolar disorder and further data are anticipated...
  30. ncbi Culture and assessment of manic symptoms
    Paul Mackin
    School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK
    Br J Psychiatry 189:379-80. 2006
    ..001) and between India and UK (P<0.001) rater groups. Overall, differences between India and US rater groups were less marked (P=0.28). These differences suggest that cultural biases influence the interpretation of manic symptoms...
  31. ncbi Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: a preliminary report
    I Nicol Ferrier
    School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, UK
    Bipolar Disord 6:319-22. 2004
    ....
  32. ncbi Perception of facial expressions of emotion in bipolar disorder
    Helen R Venn
    Stanley Research Centre, School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, UK
    Bipolar Disord 6:286-93. 2004
    ..Altered perception of facial expressions that has been found to accompany depressed mood may instead reflect mood-congruent biases...
  33. ncbi Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
    Stuart Watson
    The Stanley Research Centre, University of Newcastle upon Tyne, The Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Br J Psychiatry 184:496-502. 2004
    ..This measure of HPA axis dysfunction is a potential trait marker in bipolar disorder and thus possibly indicative of the core pathophysiological process in this illness...
  34. ncbi Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder
    Allan H Young
    Stanley Research Centre, School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, UK
    Neuropsychopharmacology 29:1538-45. 2004
    ..These data require replication but provide preliminary evidence that glucocorticoid receptor antagonists may have useful cognitive-enhancing and possibly antidepressant properties in bipolar disorder...
  35. ncbi International Consensus Group on Bipolar I Depression Treatment Guidelines
    Joseph R Calabrese
    Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA
    J Clin Psychiatry 65:571-9. 2004
  36. ncbi Corticosteroid-serotonin interactions in depression: a review of the human evidence
    Richard J Porter
    Department of Psychological Medicine, Christchurch School of Medicine, Christchurch, New Zealand
    Psychopharmacology (Berl) 173:1-17. 2004
    ..It has been suggested that corticosteroid-serotonin interactions are central to the pathophysiology of depression. These interactions have been investigated in healthy and depressed humans, primarily using neuroendocrine techniques...
  37. ncbi The pharmacological treatment of bipolar affective disorder: practice is improving but could still be better
    Adrian J Lloyd
    School of Neurology, Neurobiology and Psychiatry, University of Newcastle, Newcastle upon Tyne, UK
    J Psychopharmacol 17:230-3. 2003
    ..However, it still falls short in a number of respects of such recommendations as exist and this requires further examination and monitoring...
  38. ncbi GABA-ergic drugs: exit stage left, enter stage right
    Heather Ashton
    Department of Psychiatry, University of Newcastle upon Tyne, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    J Psychopharmacol 17:174-8. 2003
    ..It remains to be seen whether long-term use leads to tolerance, dependence and withdrawal or discontinuation reactions...
  39. ncbi Evidence for a late onset bipolar-I disorder sub-group from 50 years
    Stephen R J Moorhead
    Department of Psychiatry, University of Newcastle upon Tyne, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
    J Affect Disord 73:271-7. 2003
    ..We examined the relationship between age of onset and family history in bipolar-I disorder in an attempt to identify subgroups...
  40. ncbi Acute tryptophan depletion attenuates auditory event related potentials in bipolar disorder: a preliminary study
    Allan H Young
    Stanley Foundation Research Centre, Department of Psychiatry, University of Newcastle upon Tyne, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
    J Affect Disord 69:83-92. 2002
    ..The EEG may therefore be a sensitive marker of 5-HT function in bipolar disorder. We examined the effects of acute tryptophan depletion (ATD) on EEG activity in bipolar patients...
  41. ncbi Rapid cycling bipolar disorder: historical overview and focus on emerging treatments
    Paul Mackin
    School of Neurology, Neurobiology and Psychiatry, Department of Psychiatry, University of Newcastle upon Tyne, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Bipolar Disord 6:523-9. 2004
    ....
  42. ncbi A functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction
    Paul J Monks
    Division of Psychological Medicine, Institute of Psychiatry, London, UK
    Bipolar Disord 6:550-64. 2004
    ..CONCLUSIONS: Our findings support the notion that, in euthymic bipolar disorder, failure to engage fronto-executive function underpins the core neuropsychological deficits...
  43. ncbi Executive and visuospatial sketchpad resources in euthymic bipolar disorder: Implications for visuospatial working memory architecture
    Jill M Thompson
    University of Newcastle upon Tyne, UK
    Memory 14:437-51. 2006
    ..ANCOVA indicated that impaired executive function underpinned patients' CBT performance. Implications for the interface between executive and slave systems of working memory are discussed...
  44. ncbi The dex/CRH test--is it better than the DST?
    Stuart Watson
    School of Neurology, Neurobiology and Psychiatry, The Stanley Research Centre, University of Newcastle upon Tyne, Leazes Wing Psychiatry, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
    Psychoneuroendocrinology 31:889-94. 2006
    ..9% and the specificity 71.4%. The sensitivity of 1500 h cortisol (the DST) was 66.6% and the specificity was 47.6%. This suggests that the two tests measure common pathology but that the dex/CRH test has better diagnostic utility...
  45. ncbi A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder
    Lucy J Robinson
    School of Neurology, Neurobiology and Psychiatry (Psychiatry, University of Newcastle upon Tyne, Leazes Wing, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK
    J Affect Disord 93:105-15. 2006
    ..Future investigations should clarify the functional significance of deficits and indicate whether patients will benefit from ameliorative interventions...
  46. ncbi Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder
    Utpal Goswami
    Lady Hardinge Medical College and Associated Hospitals, New Delhi, India
    Br J Psychiatry 188:366-73. 2006
    ..CONCLUSIONS: Cognitive dysfunction, social dysfunction and soft signs occur in euthymic patients with bipolar disorder and may represent trait deficits...
  47. ncbi Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function
    Stuart Watson
    The Stanley Research Centre, School of Neurology, Neurobiology, and Psychiatry, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
    Bipolar Disord 8:85-90. 2006
    ..No such relationship was evident in controls. CONCLUSION: Deficits in declarative memory and WM are evident in patients with bipolar disorder. The deficit in retrieval accuracy from WM appears to be correlated with abnormal GR function...
  48. ncbi Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK
    Elaine K Green
    Department of Psychological Medicine, Henry Wellcome Building, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF4 4XN, Wales, UK
    Br J Psychiatry 188:21-5. 2006
    ..Three family-based studies have shown association of the common Valine (Val) allele of the Val66Met polymorphism of the BDNF gene with susceptibility to bipolar disorder...
  49. ncbi Effect of lithium and lithium withdrawal on potassium-evoked dopamine release and tyrosine hydroxylase expression in the rat
    Lindsey Ferrie
    Psychobiology Research Group, School of Neurology, Neurobiology and Psychiatry, The Medical School, Newcastle upon Tyne, UK
    Int J Neuropsychopharmacol 9:729-35. 2006
    ..These data suggest that decreased dopamine release may mediate the mood stabilizing action of lithium. However, in this paradigm a rebound increase in dopamine release was not found after withdrawal from lithium treatment...
  50. ncbi Using guidelines in real clinical situations: clozapine and breast feeding in bipolar disorder
    Guy Goodwin
    University Department of Psychiatry, Warneford Hospital, Oxford, UK
    J Psychopharmacol 19:317-8. 2005
  51. ncbi Temporal stability of the dex/CRH test in patients with rapid-cycling bipolar I disorder: a pilot study
    Stuart Watson
    Department of Psychiatry, Leazes Wing, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, U.K
    Aust N Z J Psychiatry 39:244-8. 2005
    ..997; p < 0.0005). CONCLUSION: The data suggests that the cortisol response to the dex/CRH test is stable over time and independent of mood state...
  52. ncbi Neurocognitive impairment in euthymic patients with bipolar affective disorder
    Jill M Thompson
    Stanley Research Centre, School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK
    Br J Psychiatry 186:32-40. 2005
    ..CONCLUSIONS: Neurocognitive impairment persists in patients whose bipolar disorder is in remission. This may represent a trait abnormality and be a marker of underlying neurobiological dysfunction...
  53. ncbi Effects of acute tryptophan depletion on cognitive function in euthymic bipolar patients
    John H Hughes
    Stanley Foundation Research Centre, Department of Psychiatry, University of Newcastle-upon-Tyne, Leazes Wing, Royal Victoria Infirmary, Newcastle-upon-Tyne NE1 4LP, UK
    Eur Neuropsychopharmacol 12:123-8. 2002
    ..Effects on specific 'executive' functions are less clear, and should be the focus for future research...